GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Market Cap

International Biotechnology Trust (LSE:IBT) Market Cap : £229.69 Mil (As of May. 25, 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). International Biotechnology Trust's share price for the quarter that ended in Feb. 2024 was £6.84. International Biotechnology Trust's Shares Outstanding (EOP) for the quarter that ended in Feb. 2024 was 38.26 Mil. Therefore, International Biotechnology Trust's market cap for the quarter that ended in Feb. 2024 was £261.68 Mil.

International Biotechnology Trust's quarterly market cap declined from Feb. 2023 (£281.28 Mil) to Aug. 2023 (£253.21 Mil) but then increased from Aug. 2023 (£253.21 Mil) to Feb. 2024 (£261.68 Mil).

International Biotechnology Trust's annual market cap declined from Aug. 2021 (£301.89 Mil) to Aug. 2022 (£266.22 Mil) and declined from Aug. 2022 (£266.22 Mil) to Aug. 2023 (£253.21 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. International Biotechnology Trust's Enterprise Value for Today is £248.13 Mil.


International Biotechnology Trust Market Cap Historical Data

The historical data trend for International Biotechnology Trust's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Market Cap Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 244.21 280.59 301.89 266.22 253.21

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 261.76 266.22 281.28 253.21 261.68

Competitive Comparison of International Biotechnology Trust's Market Cap

For the Asset Management subindustry, International Biotechnology Trust's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Market Cap Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's Market Cap distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Market Cap falls into.



International Biotechnology Trust Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

International Biotechnology Trust's Market Cap for the fiscal year that ended in Aug. 2023 is calculated as

Market Cap (A: Aug. 2023 )=Share Price (A: Aug. 2023 )*Shares Outstanding (EOP) (A: Aug. 2023 )
=£6.44*39.3182
=£253.21

International Biotechnology Trust's Market Cap for the quarter that ended in Feb. 2024 is calculated as

Market Cap (Q: Feb. 2024 )=Share Price (Q: Feb. 2024 )*Shares Outstanding (EOP) (Q: Feb. 2024 )
=£6.84*38.2574
=£261.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Biotechnology Trust  (LSE:IBT) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


International Biotechnology Trust Market Cap Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines